Targeted Muscle Reinnervation to Expendable Motor Nerves for the Treatment of Refractory Symptomatic Neuromas in Nonamputees

Summary:. Symptomatic neuromas can cause debilitating pain, significantly impairing patients’ quality of life. There are numerous medical and surgical options for management. Targeted muscle reinnervation (TMR) is a nerve transfer procedure that is now commonly used to prevent or treat symptomatic n...

Full description

Bibliographic Details
Main Authors: Brian L. Chang, MD, Patrick Harbour, MD, Josh Mondshine, BS, Grant M. Kleiber, MD
Format: Article
Language:English
Published: Wolters Kluwer 2021-02-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003436
_version_ 1819172503325507584
author Brian L. Chang, MD
Patrick Harbour, MD
Josh Mondshine, BS
Grant M. Kleiber, MD
author_facet Brian L. Chang, MD
Patrick Harbour, MD
Josh Mondshine, BS
Grant M. Kleiber, MD
author_sort Brian L. Chang, MD
collection DOAJ
description Summary:. Symptomatic neuromas can cause debilitating pain, significantly impairing patients’ quality of life. There are numerous medical and surgical options for management. Targeted muscle reinnervation (TMR) is a nerve transfer procedure that is now commonly used to prevent or treat symptomatic neuromas or phantom limb pain in amputees. There are a few reports in the current literature about performing TMR in the nonamputee, but no cohort studies to date that report pain outcomes. This study evaluates TMR to treat symptomatic neuromas in nonamputee patients. This is a retrospective cohort study of all patients with symptomatic neuromas treated with TMR over a 1-year period from January 1,2019, to January 1, 2020, at MedStar Georgetown University Hospital. The neuromas are excised to healthy nerve fascicles, and a redundant donor motor fascicle is selected for nerve transfer. Patients were asked in clinic or via telephone about their preoperative and postoperative pain, function, and quality of life, and postoperative clinic notes were reviewed for complications and motor deficits. Fifteen patients were included in this study. Patients had symptomatic neuromas involving the upper extremity, lower extremity, and trunk. Pain frequency decreased from 6.7 times per week to 3.9 (P < 0.01) and from 9.1 times per day to 5.1 (P < 0.01). Pain severity decreased from an average of 7.9/10 to 4.3/10 (P < 0.01). Overall physical function increased from 3.7/10 to 5.8/10 (P = 0.01), and overall quality of life increased from 4.9/10 to 7.0/10 (P < 0.01). No patients had demonstrable weakness of the motor function of the donor nerve. Targeted muscle reinnervation is a viable surgical option for the treatment of symptomatic neuromas, particularly in those patients who have previously failed prior neuroma excisions.
first_indexed 2024-12-22T20:08:13Z
format Article
id doaj.art-337ea5215b6d4e78ac1bd671eb508309
institution Directory Open Access Journal
issn 2169-7574
language English
last_indexed 2024-12-22T20:08:13Z
publishDate 2021-02-01
publisher Wolters Kluwer
record_format Article
series Plastic and Reconstructive Surgery, Global Open
spelling doaj.art-337ea5215b6d4e78ac1bd671eb5083092022-12-21T18:14:06ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742021-02-0192e343610.1097/GOX.0000000000003436202102000-00019Targeted Muscle Reinnervation to Expendable Motor Nerves for the Treatment of Refractory Symptomatic Neuromas in NonamputeesBrian L. Chang, MD0Patrick Harbour, MD1Josh Mondshine, BS2Grant M. Kleiber, MD3From the * Department of Plastic Surgery, MedStar Georgetown University Hospital; Washington, D.C.† Department of Plastic Surgery, MedStar Georgetown University Hospital; Washington, D.C.‡ Georgetown University School of Medicine, Washington, D.C.§ Department of Plastic Surgery, MedStar Georgetown University Hospital; Washington, D.C.Summary:. Symptomatic neuromas can cause debilitating pain, significantly impairing patients’ quality of life. There are numerous medical and surgical options for management. Targeted muscle reinnervation (TMR) is a nerve transfer procedure that is now commonly used to prevent or treat symptomatic neuromas or phantom limb pain in amputees. There are a few reports in the current literature about performing TMR in the nonamputee, but no cohort studies to date that report pain outcomes. This study evaluates TMR to treat symptomatic neuromas in nonamputee patients. This is a retrospective cohort study of all patients with symptomatic neuromas treated with TMR over a 1-year period from January 1,2019, to January 1, 2020, at MedStar Georgetown University Hospital. The neuromas are excised to healthy nerve fascicles, and a redundant donor motor fascicle is selected for nerve transfer. Patients were asked in clinic or via telephone about their preoperative and postoperative pain, function, and quality of life, and postoperative clinic notes were reviewed for complications and motor deficits. Fifteen patients were included in this study. Patients had symptomatic neuromas involving the upper extremity, lower extremity, and trunk. Pain frequency decreased from 6.7 times per week to 3.9 (P < 0.01) and from 9.1 times per day to 5.1 (P < 0.01). Pain severity decreased from an average of 7.9/10 to 4.3/10 (P < 0.01). Overall physical function increased from 3.7/10 to 5.8/10 (P = 0.01), and overall quality of life increased from 4.9/10 to 7.0/10 (P < 0.01). No patients had demonstrable weakness of the motor function of the donor nerve. Targeted muscle reinnervation is a viable surgical option for the treatment of symptomatic neuromas, particularly in those patients who have previously failed prior neuroma excisions.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003436
spellingShingle Brian L. Chang, MD
Patrick Harbour, MD
Josh Mondshine, BS
Grant M. Kleiber, MD
Targeted Muscle Reinnervation to Expendable Motor Nerves for the Treatment of Refractory Symptomatic Neuromas in Nonamputees
Plastic and Reconstructive Surgery, Global Open
title Targeted Muscle Reinnervation to Expendable Motor Nerves for the Treatment of Refractory Symptomatic Neuromas in Nonamputees
title_full Targeted Muscle Reinnervation to Expendable Motor Nerves for the Treatment of Refractory Symptomatic Neuromas in Nonamputees
title_fullStr Targeted Muscle Reinnervation to Expendable Motor Nerves for the Treatment of Refractory Symptomatic Neuromas in Nonamputees
title_full_unstemmed Targeted Muscle Reinnervation to Expendable Motor Nerves for the Treatment of Refractory Symptomatic Neuromas in Nonamputees
title_short Targeted Muscle Reinnervation to Expendable Motor Nerves for the Treatment of Refractory Symptomatic Neuromas in Nonamputees
title_sort targeted muscle reinnervation to expendable motor nerves for the treatment of refractory symptomatic neuromas in nonamputees
url http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003436
work_keys_str_mv AT brianlchangmd targetedmusclereinnervationtoexpendablemotornervesforthetreatmentofrefractorysymptomaticneuromasinnonamputees
AT patrickharbourmd targetedmusclereinnervationtoexpendablemotornervesforthetreatmentofrefractorysymptomaticneuromasinnonamputees
AT joshmondshinebs targetedmusclereinnervationtoexpendablemotornervesforthetreatmentofrefractorysymptomaticneuromasinnonamputees
AT grantmkleibermd targetedmusclereinnervationtoexpendablemotornervesforthetreatmentofrefractorysymptomaticneuromasinnonamputees